Clinical development of medicinal products for the treatment of allergic rhino-conjunctivitis

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/2455/02
Effective from01/05/2005
KeywordsAllergen,  seasonal and perennial allergic rhino-conjunctivitis
DescriptionThis document addresses issues of study design, efficacy and safety for new medicinal products intended for the symptomatic treatment and overall pharmacological management of allergic rhino-conjunctivitis.

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more